As the number of men and women entering treatment for
INTRODUCTION
Viewing and managing substance abuse disorders as health problems 1 has established the need for expanding assessment measurements used for planning and evaluat-ing treatment programs. Assessment measures most widely used in substance abuse treatment planning and evaluations have typically focused on the following core areas: substance use behaviors, criminal involvement, employment and educational status, social/family relationships, as well as medical and psychiatric functioning. 2, 3 A common measure routinely used in public health for planning and evaluation of programs is quality of life (QOL) or patient perceived health status. 4, 5 Given the wealth of research establishing the substantial strains of substance use on co-occurring medical disabilities, mental health problems, 6 and legal issues 7, 8 it can be inferred that substancedependent individuals may be at heightened risk for poor QOL. 9 One drug that has posed much challenge to the substance abuse treatment community is methamphetamine (MA). 10 MA-admissions to publicly funded treatment programs have remained fairly stable over the past years, wavering between 12% and 13%. 11 Findings from a large body of clinical and behavioral research with MA-dependent individuals imply that these individuals may be especially vulnerable for poor QOL or health status perceptions. Specifically, MA dependence is associated with formidable medical conditions affecting multiple organ systems 12 and psychiatric co-morbidity 13 including cardiovascular and neurological complications as well as psychosis and depression, suicidal ideations, auditory hallucinations, and paranoia. 14, 15 A recent investigation of MA-related emergency department visits found that mental health problems, trauma, skin infections, and dental pathology were the most common health issues associated with MA use. 16 To date, there is limited research on QOL or patient perceived health status among MA-dependent individuals. Brecht and colleagues 17 have reported on the health status of MA users, although the measurement used was general and not specific to QOL standardized assessment, such as the Short Form Health Survey (SF-36, SF-20, and SF-12) or the Nottingham Health Profile (NHP). Using data from a multisite randomized clinical trial, this study assesses QOL or perceived health status using the SF-36 among a MA-dependent clinical sample at admission to outpatient treatment programs.
METHODS

Sample
The sample is comprised of 838 MA-dependent individuals who participated in a Methamphetamine Treatment Project (MTP) between 1999 and 2001. 18 Eligibility for MTP participation included meeting substance dependence Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for MA, using MA within the month before treatment entry, geographic proximity to the treatment location, and English language proficiency. Upon admission, MTP participants were randomly assigned to receive a 16-week treatment using the Matrix Model or treatment as usual 19 in eight outpatient treatment programs within California, Montana, and Hawaii. The study was conducted under the review and approval of the Institutional Review Board (IRB) of the University of California, Los Angeles, as well as the local IRBs for each participating treatment site.
Measures
Data used for this study were collected from the SF-36 20 and Addiction Severity Index (ASI) fifth edition.
21
The SF-36 is a generic self-report measure of QOL. It is comprised of 36 items assessing perceived health status across four physical subscales measuring physical functioning, role limitations due to physical functioning, bodily pain, and general health, as well as four mental subscales measuring vitality, social functioning, role limitations due to emotional functioning, and emotional well-being. Scores for these eight subscales are combined into two summary scales-physical component summary (PCS) and mental component summary (MCS). 22 Scales are scored from 0 to 100, with higher scores indicating better QOL or perceived health status. The ASI is a psychometrically validated, multidimensional instrument that collects sociodemographic, psychosocial, and drug use information. 21 The ASI gauges problem severity by calculating composite scores across seven domains: drug, alcohol, legal, family, employment, medical, and psychiatric domains ranging from 0 (no problem) to 1 (extreme severity), with higher scores indicative of more impairment.
Data Analysis
Multiple linear regression was performed to examine predictors of QOL or perceived health status among the MA-dependent sample at treatment admission. Predictor variables assessed for were measured by the ASI at treatment admission and included sociodemographic, psychosocial, drug use severity, and psychiatric and medical factors that have been shown to affect treatment outcomes. 23, 24 Gender, age, race, marital status, living situation, educational attainment, employment status, and religious preference comprised the sociodemographic variables. Psychosocial variables included lifetime trauma as indicated by experiencing physical, emotional or sexual abuse, lifetime suicide as defined by attempting suicide at least once over the course of one's life, and family and social conflict in the month prior to treatment entry. Drug use severity measures included frequency of MA and polydrug use, drug use chronicity (lifetime use of both MA and polydrugs), route of administration, and number of past treatments for substance abuse. Measures of psychiatric and medical impairment measured by ASI composite scores were also included.
Regression diagnostics showed that all key assumptions of independence, linearity, homoscedasticity, and normality were met and no multicollinearity problems were encountered when tolerance and variance inflation factors were analyzed. The Statistical Package for Social Sciences (SPSS), version 14.0 was used for all analyses, with an alpha level (2-tailed) set at p < .05 for statistical significance.
RESULTS
Sociodemographic Characteristics
A clinical assessment of substance use disorders was performed on all participants (N = 838) and 100% met criteria for MA dependence. Females represented roughly half of the sample (51.1%). Most patients were White (63%). Other ethnic groups represented included Hispanic (18%), Asian/Pacific Islander (14.1%), African American (1.9%), and Native American/Alaskan Indian (3.0%). The average age of the sample was 31.4 ± 8.03 years (range 18-60). Approximately 17.2% of the sample were married, almost half (49.9%) had never been married, and 33.1% were divorced/separated/or widowed. The majority of the sample was employed (73.3%) and 77.7% had a high school education or more. Less than a quarter (19.5%) of the sample reported not having stable living arrangements. In addition, a majority of participants reported having a religious preference (68.2%).
Psychosocial Factors
Many participants reported lifetime trauma (78.8%) and about one-third (33.7%) reported past suicide attempts. The sample also reported experiencing a high level of interpersonal conflict within social settings (33.3%) and with family (45.3%) during the prior month of treatment admission.
Drug Use Severity Factors
The frequency of MA use averaged 12 (SD = 9.0) days and 5 (SD = 7.0) days for polydrug use in the month prior to admission. Use greater than or equal to 15 days in the month prior to admission was fairly moderate for MA use (38%) and relatively low for polydrug use (15%). The chronicity of drug use was extensive, such that 49% and 53% of the sample reported both polydrug use and MA use for six or more years prior to admission. In general, the average lifetime use for MA was 7.4 (sd = 6.0) years and 6.6 (sd = 7.0) years for polydrug use. The most common route of administration for MA was smoking (65.2%), followed by injecting (24%) and intranasal use (10.2%). Approximately half (49.6%) of the sample had been in drug treatment prior to their current treatment enrollment.
Psychiatric and Medical Factors
The amount of psychiatric and medical impairment reported among the MA sample at treatment admission was moderate, averaging 0.21 ± 0.30 and 0.23 ± 0.21, respectively as measured by the ASI composite scales.
QOL at Treatment Admission
Using the SF-36, approximately 44% of the MA sample rated their health as "good," 25% reported it as "fair or poor," while only 7% rated it as "excellent." Table 1 presents comparative differences in QOL or patient perceived health status between the MA sample at treatment admission and the normative U.S. population. 25 Using calculated z-scores and 95% confidence intervals, the clinical MA sample had significantly lower perceptions of health status/QOL across each of the mental and physical health SF-36 scales, with the exception of physical functioning compared to normative U.S. data. Scores were particularly lowest for the mental health scales compared to the physical health scales.
Regression Analyses
Given that preliminary analyses showed very similar results for the eight SF-36 subscales and two component scales, linear regression analyses reported only examine predictors of QOL (sociodemographic, psychosocial, drug use severity, and psychiatric/medical factors) using the component scales-PCS and MCS.
Predictors of QOL at Treatment Admission Table 2 displays results predicting perceived physical health status at treatment admission. The model was significant (F = 12.456 20, 797 , p < .001), accounting for 23.8% of explained variance. As shown, controlling for all factors, significant predictors of poor physical health status perceptions as measured by the PCS included female gender (b = −1.493, p < .01), lifetime suicide history (b = −.655, p < .05), and existing medical impairment (b = −13.327, p < .001). Table 3 Note: U.S. analytic sample using SF-36 user's manual; Range: 0-100. * p < .05. perceptions as measured by the MCS. Additionally, being employed was significantly related to having a better mental health status (b = 1.543, p < .05).
DISCUSSION
QOL research among substance abusers in general remains an area of inquiry in need of more investigation. This paper examined QOL or perceptions of health status among a MA-dependent clinical sample entering outpatient treatment. Given the standardization of the SF-36, it is a very useful tool for comparing norms or mean differences in QOL among different populations; however to date, there are no published SF-36 data on the health status of MA-dependent users compared with population norms. Using the SF-36, results highlight that, on average, MA users reported significantly poorer QOL/perceived health status compared with normative population data, especially among the mental health subscales, roughly 10-12 points lower. However, the physical health status reported among the MA sample was not that different relative to normative rates. This result may be due to the youthfulness of the MA sample (average age was 33) compared to the general population used in the Medical Outcomes Study (average age was 55). Moreover, while age seems to play a role in explaining QOL among the general population and other studies with older substance dependent users, [26] [27] [28] when entered in the predictive models in this study, it did not have any explanatory value in the mental or physical health outcomes.
Regression model findings are useful from a clinical perspective as they offer insight into factors related to QOL or perceived health status among MA patients at treatment entry. Sociodemographic factors that were significant predictors of QOL included gender, education, and marital status. While previous studies support the notion that women MA users are likely to have poorer mental and physical health status perceptions than men, 27, [29] [30] [31] [32] this finding is important as differences in QOL/health status perceptions may relate to treatment adherence or posttreatment outcomes, hence should be considered at treatment planning.
The finding that MA users with a higher education (12th grade or higher) were more likely to have poorer mental health status perceptions compared to those with lower educational levels was unanticipated and not supported by the literature, 33 as lower levels of education tend to be associated with poorer QOL and worse health. One possible speculation for this result is that drug use among highly educated persons may lead to a sense of failure in terms of not being able to successfully fulfill the roles and health standards they set out to accomplish prior to their drug use. Hence, the perception of health states of the more educated MA users may be that their drug use has compromised their health status more than less educated persons, who may not have set originally high goals and aspirations. Given this finding, providers should examine treatment outcome expectancies of MA patients with more education as this area may also be jeopardized due to accomplishment or achievement issues. The finding that married MA users had poorer mental QOL was also not anticipated, as the literature shows married people, in general are healthier than unmarried people and it is unmarried persons who are supposed to have higher morbidity and mortality health-related outcomes. 28 A possible explanation for this counterintuitive finding with MA users is that MA use can be related to more interpersonal dysfunction among families, as was supported by the high interpersonal social conflict reported among the sample; hence, this conflict may be a root factor for marital distress and the resulting poor health status perceptions. Another reason may be due to being in abusive relationships, as is commonly found among MA users. 34 Consistent with previous literature in the area of trauma and interpersonal wellness, 26, 35 this study also found that MA users with history of trauma (including sexual, physical, and emotional abuse), lifetime suicidal past attempts, and social conflict had poorer mental health perceptions compared to those without such interpersonal distress. Findings also confirm the established finding that past suicide behavior is an important psychosocial predisposing risk factor for poor mental health status. 36 Likewise, the finding that social conflict at treatment admission significantly predicted poor physical health status is supported by other health outcome studies in the literature, 37, 38 which show that one's physical health is greatly dependent on interpersonal functioning.
This study also found that QOL/health status perceptions were significantly related to drug use severity at admission as measured by proxy measures of frequency, chronicity, and route of use. Specifically, the frequency of MA and polydrug use (in the month before admission) as defined by a clinical threshold of greater or equal to 15 days was predictive of poor mental and physical health status perceptions among the sample. Similarly, MA users with longer histories of MA and polydrug use (defined by 6 or more lifetime years) reported poorer health status perceptions at admission. These findings are similar to a recent study that found patients who used MA and alcohol in high levels reported lower QOL compared to those who reported infrequent use. 39 We also found that injection use was associated with poorer QOL at admission compared to noninjection use, a finding that has been supported by a growing body of studies in the literature looking at the clinical and health implications associated with route of administration. 40, 41 Because studies have demonstrated that psychiatric and medical impairment measured by ASI composite scores can serve as a sufficient screener for physical and mental health impairment in drug-dependent patients, 42 this study assessed the extent to which medical and psychiatric impairment (measured by ASI composite scores) affected QOL/health status perceptions at treatment entry. Confirming the inverse relationship between comorbidity and QOL found in previous studies with drug users, [43] [44] [45] this study also found that MA users with high medical and psychiatric dysfunction before treatment entry had poorer health status perceptions. From a clinical perspective, assessing levels of psychiatric and medical impairment among drug users prior to treatment entry is important given the high prevalence of co-occurring psychiatric and medical disorders among such individuals 46 and the influence these factors have in contributing to one's treatment success or failure. 47 Furthermore, although the existence of this association makes logical sense, it still has to be demonstrated and thoroughly studied to find ways of improving care for patients with substance abuse and co-occurring medical and psychiatric symptoms.
Limitations
The data reported in this paper are based on patient self-report. This is limiting especially for the measures that assess physical and mental health impairment as these are not objective measures that assess the extent to which actual clinically determined medical and psychiatric comorbidities, such as HIV, Hepatitis C, or clinical depression can impact perceived health status. Because this is the first study to look at QOL among a MA-dependent treatment sample, there are no other studies to reference, so implications as to why MA users rate their physical health as nonproblematic or why having a higher education is correlated with poorer QOL is left open for exploration.
Because the health status of MA-dependent persons is associated with multiple individual and social problems, there are other unmeasured factors worth considering in future research with Health-Related Quality of Life (HRQOL)-related studies among MA users. Future research for example, can look at measures of income and poverty, homelessness status, and social support structures to get a better sense of how more macro-level factors play a role in shaping and influencing the QOL of MA users. While this study used lifetime suicide and trauma to contextualize "life events" that can impact the health status of individuals, future studies can explore the impact of current suicide ideation and current trauma experiences on QOL health status perceptions as well. This study did not investigate the impact of legal issues on one's health status before treatment, which may be worth considering in future studies since there has been increasing rates of MA-abusing individuals in the criminal justice system. 48 Not only does time in jail and prison exact a high cost to society, such confinement also has deleterious consequences on an individual's well-being. 49 Hence, criminal justice involved MA users are an important group to consider for future research on QOL.
CONCLUSION
This study expands the scope of scholarly examination of MA-dependent users entering treatment, as there has not been a development of coherent profiles of QOL among representative samples of clinical MA-abusing populations to date. The results from this study are especially useful to treatment providers, since MA is a drug that has received heightened attention from national, state, and local public health authorities as a major health threat and the routine monitoring of patient "health" is an important goal of treatment programs. From a treatment planning perspective, routine monitoring of health status can identify target areas for health promotion and intervention. Results highlight some important clinical determinants of QOL that should be considered with MA-dependent clinical samples at treatment entry as targets of change, including drug severity behaviors (ie, frequency of MA use, polydrug use, and injection behaviors), interpersonal family/social dysfunction, and medical and psychiatric comorbidities. Overall, a thorough understanding of QOL among MA users and related factors can benefit providers by being able to identify risks and barriers that can serve to exacerbate substance dependence and worsen treatment outcomes.
